Biosplice Therapeutics said the first patient has
Browsing: All news
Category Added in a WPeMatico Campaign
An end-of-year experiment exploring how large la
Devin Partida on the fine line between longevity
Startup targets ‘brainspan’ with EEG-powered
A new MRM Health R&D partnership in immunotherap
A lipidomics analysis of young Chinese women fin
NorthStrive Biosciences, a subsidiary of PMGC Hol
“ProMIS Neurosciences announced that its PRECIS
Annovis Bio said it will begin an open-label exte
MUVON Therapeutics announced that Dr Christine Günther, MD, PhD, has been appointed Chief Technology Officer (CTO), effective December 1, 2025, as the clinical-stage biotech advances its regenerative medicine platform for skeletal muscle tissue repair. The company said her addition will…